Cargando…
Have we been qualifying measurable residual disease correctly?
Autores principales: | Feng, Yahui, Qi, Saibing, Liu, Xueou, Zhang, Li, Hu, Yu, Shen, Qiujin, Gong, Xiaowen, Zhang, Wei, Wang, Junxia, Yan, Wen, Wang, Tiantian, Wang, Huijun, Song, Zhen, Zhu, Xiaofan, Gale, Robert Peter, Chen, Junren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624632/ https://www.ncbi.nlm.nih.gov/pubmed/37704711 http://dx.doi.org/10.1038/s41375-023-02026-4 |
Ejemplares similares
-
Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery?
por: Chen, Junren, et al.
Publicado: (2023) -
Correction: Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery?
por: Chen, Junren, et al.
Publicado: (2023) -
50 Years of Women in Cell Biology: Where have we been? Where are we going?
por: Masur, Sandra K., et al.
Publicado: (2021) -
‘Dynamic zero-COVID’ policy and viral clearance during an omicron wave in Tianjin, China: a city-wide retrospective observational study
por: Feng, Yahui, et al.
Publicado: (2022) -
How should we interpret conclusions of TKI-stopping studies
por: Gale, Robert Peter, et al.
Publicado: (2023)